50th Participant Enrolls in Smoked Marijuana Trial for Chronic PTSD in Veterans

On March 28, 2018, the 50th of 76 participants enrolled and received study drug in the first-ever clinical trial of smoked marijuana (cannabis) for posttraumatic stress disorder (PTSD) in U.S. veterans. Taking place at the Scottsdale Research Institute (SRI) in Phoenix, Arizona, this clinical trial will evaluate the safety and efficacy of four different potencies of marijuana for symptoms of PTSD in 76 U.S. veterans. A new recruitment website can be visited here. On March 26 – 29, Gabby Fortier, Clinical Research Associate, will monitor the site. Learn more… | Visit the Recruitment Website